RXSIGHT INC's ticker is and the CUSIP is 78349D107. A total of 54 filers reported holding RXSIGHT INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,016,475 | -75.5% | 72,301 | -74.7% | 0.00% | -100.0% |
Q2 2023 | $8,227,411 | +533.0% | 285,674 | +266.6% | 0.00% | – |
Q1 2023 | $1,299,705 | +248.5% | 77,920 | +164.7% | 0.00% | – |
Q4 2022 | $372,967 | +30.0% | 29,437 | +23.2% | 0.00% | – |
Q3 2022 | $287,000 | -32.0% | 23,896 | -20.3% | 0.00% | – |
Q2 2022 | $422,000 | – | 29,988 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Divisadero Street Capital Management, LP | 680,000 | $18,965,200 | 5.98% |
NEXT CENTURY GROWTH INVESTORS LLC | 747,827 | $20,856,895 | 2.27% |
Parkman Healthcare Partners LLC | 381,331 | $10,635,322 | 1.95% |
Atika Capital Management LLC | 509,352 | $14,205,828 | 1.86% |
RA Capital Management | 3,052,796 | $85,142,480 | 1.68% |
EAM Investors, LLC | 163,168 | $4,550,756 | 0.88% |
No Street GP LP | 250,000 | $6,972,500 | 0.83% |
ADVISORY RESEARCH INC | 156,189 | $4,356,112 | 0.60% |
Lisanti Capital Growth, LLC | 123,205 | $3,436,187 | 0.54% |
Alpha DNA Investment Management LLC | 20,879 | $582,315 | 0.24% |